Clotrimazole IP/BP/EP/USP

Clotrimazole IP/BP/EP/USP is a trusted and widely used antifungal agent, recognized for its exceptional effectiveness in treating various fungal infections. Additionally, this compound, also referred to as Clotrimazole API, holds significant value in pharmaceutical applications due to its potent ability to inhibit fungal growth. Chemically identified as 1-[(2-Chlorophenyl)diphenylmethyl]-1H-imidazole, Clotrimazole plays a critical role in the formulation of both topical and systemic antifungal treatments. With a molecular formula of C22H17ClN2 and a molecular weight of 344.8, its intricate structure ensures efficacy and reliability in medical applications.

Moreover, Clotrimazole IP/BP/EP/USP belongs to the therapeutic category of antifungals, making it indispensable in combating infections caused by a variety of fungal pathogens. Physically, it appears as a white crystalline powder, signifying its high purity and suitability for pharmaceutical use. Additionally, its packaging in 25 kg export-quality HDPE or FIBRO drums, secured with double liners, provides enhanced protection during storage and transport. This meticulous packaging process guarantees the compound’s stability and preserves its quality throughout its shelf life.

Furthermore, to maintain its effectiveness, Clotrimazole must be stored in well-closed containers, away from light and moisture. These controlled storage conditions ensure that the compound remains ready for use in diverse pharmaceutical formulations. Thanks to its antifungal potency and pharmaceutical-grade quality, Clotrimazole IP/BP/EP/USP meets the demands of manufacturers and healthcare providers worldwide.

By delivering consistent results and supporting innovative medical treatments, Clotrimazole API continues to be a cornerstone in the development of effective antifungal therapies. Whether used in creams, solutions, or systemic treatments, this compound upholds its reputation as a reliable and essential ingredient in pharmaceutical advancements.